IQVIA on reducing complexity and workload for clinical trial sites

As clinical research sites come under growing operational pressure, sponsors and CROs are being challenged to rethink how studies are designed and supported. Protocols are becoming more complex. Technology stacks continue to expand. Yet, many sites are still expected to deliver more with the same resources, creating an environment where operational burden can quickly affect both staff and patients.

In a new sponsored video, pharmaphorum Deep Dive editor Eloise McLennan spoke with IQVIA’s Kerry Gorman, Head, NA Strategic Site Solutions, about what a more streamlined, site-centric approach could look like in practice. Their conversation explores the realities of site burnout, the impact of fragmented systems across clinical trials, and why trial readiness is now becoming a far more strategic consideration before the first patient even walks through the door.

Watch the video today to hear how IQVIA is approaching site enablement and operational simplification, alongside the wider industry changes that may be needed to support research sites and improve the clinical trial experience for staff and patients alike.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialisation of innovative medical treatments to help improve patient outcomes and population health worldwide.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analysing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviours and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.